相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment-related mortality in children with cancer: Prevalence and risk factors
Erik A. H. Loeffen et al.
EUROPEAN JOURNAL OF CANCER (2019)
Effect of Caspofungin vs Fluconazole Prophylaxis on Invasive Fungal Disease Among Children and Young Adults With Acute Myeloid Leukemia: A Randomized Clinical Trial
Brian T. Fisher et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial
S. Leroux et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study
Sharat Chandra et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Pharmacokinetics of extended dose intervals of micafungin in haematology patients: optimizing antifungal prophylaxis
E. W. Muilwijk et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis
Cinzia Auriti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Prediction of Fat-Free Mass in Children
Hesham Saleh Al-Sallami et al.
CLINICAL PHARMACOKINETICS (2015)
Micafungin twice weekly as antifungal prophylaxis in paediatric patients at high risk for invasive fungal disease
K. Bochennek et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Population Pharmacokinetics of Micafungin and Its Metabolites M1 and M5 in Children and Adolescents
William W. Hope et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Pharmacokinetics of micafungin in subjects with severe hepatic dysfunction
Nasrullah Undre et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2015)
A rationale for reduced-frequency dosing of anidulafungin for antifungal prophylaxis in immunocompromised patients
R. J. M. Bruggemann et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Effect of azole antifungal therapy on vincristine toxicity in childhood acute lymphoblastic leukaemia
Rosalin M. van Schie et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Alternate-Day Micafungin Antifungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pharmacokinetic Study
Parinda A. Mehta et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Population pharmacokinetic analysis of micafungin in Japanese patients with fungal infections
Kenji Tabata et al.
DRUG METABOLISM AND PHARMACOKINETICS (2006)
Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction
MF Hebert et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Safety, tolerability, and pharmacokinetics of micafungin (FK463) in febrile neutropenic pediatric patients
NL Seibel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation
JAH van Burik et al.
CLINICAL INFECTIOUS DISEASES (2004)
分享论文
